LCA-60

N/A

Report date: 2025/04/14 16:57:32

Base Information

Drug NameLCA-60
Drug Alias NameLCA-60
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionDipeptidyl peptidase IV modulators
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsCoronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHumabs Biomed SaVir Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesHumabs Biomed Sa
Inactive CompaniesN/A
Active IndicationsCoronavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A